Prostate and Urologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer... Laboratory Biomarker Analysis, Placebo, Rilimogene Galvacirepvec NCT02326805 National Cancer Institute (NCI) Active, not recruiting
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma sulindac, placebo, laboratory biomarker analysis NCT00841204 National Cancer Institute (NCI) Completed
Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies Dutasteride, Placebo NCT01594502 University of Illinois at Chicago Active, not recruiting
Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation cholecalciferol NCT01447355 National Cancer Institute (NCI) Completed

Pages